The patients treated with belimumab showed a trend of improvement in renal recurrence, renal remission, renal disease improvement proteinuria, and other indicators after the 52nd week, but the difference was only statistically significant in the reduction of proteinuria [ 14 ].
← all excerpts
Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis.
1
—
—